Steven M. Toler
CIK 1551721 · View on SEC EDGAR ↗
First SEC filing: June 11, 2012 · Latest: June 11, 2012
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 17, 2014 | GYRE | A | 45,000 | — | — | 46,000 Direct | +4500.00% | Acquired | (price as of 2026-08-19) |
| Jan. 23, 2014 | GYRE | A | 45,000 | — | — | 45,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Jan. 17, 2013 | GYRE | A | 45,000 | — | — | 45,000 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 23, 2014 | GYRE | Stock Option (Right to Buy) | Common Stock, $0.001 par value per share (45,000) | $4.74 | Jan. 22, 2024 | 45,000 | Acquired |
| Jan. 17, 2013 | GYRE | Stock Option (Right to Buy) | Common Stock (45,000) | $4.63 | Jan. 16, 2023 | 45,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 8 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 11, 2012 | GYRE | Common Stock | 1,000 | Direct |
| June 11, 2012 | GYRE | Stock Option (Right to Buy)→ Common Stock (3,000) | 3,000 | Direct |
| June 11, 2012 | GYRE | Stock Option (Right to Buy)→ Common Stock (525) | 525 | Direct |
| June 11, 2012 | GYRE | Stock Option (Right to Buy)→ Common Stock (3,500) | 3,500 | Direct |
| June 11, 2012 | GYRE | Stock Option (Right to Buy)→ Common Stock (17,000) | 17,000 | Direct |
| June 11, 2012 | GYRE | Stock Option (Right to Buy)→ Common Stock (15,000) | 15,000 | Direct |
| June 11, 2012 | GYRE | Stock Option (Right to Buy)→ Common Stock (25,625) | 25,625 | Direct |
| June 11, 2012 | GYRE | Stock Option (Right to Buy)→ Common Stock (75,000) | 75,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2014 | $265,225 | $40,051 | — | — | — | — | $10,400 | $578,476 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.